Homepage
Author:
Shanghai Pride Communication
Posted Date:
March 25, 2026
BrightGene Announces Positive Topline Phase 1 Results of Oral BGM0504 in Obesity in China and the United States
Shanghai Pride Communication
March 25, 2026